Complexation of 2-acetylpyridine- and 2-benzoylpyridine-derived hydrazones to copper(II) as an effective strategy for antimicrobial activity improvement

Complexes [Cu(2AcPh)Cl]center dot 2H(2)O (1), [Cu(2AcpClPh)Cl]center dot 2H(2)O (2), [Cu(2AcpNO(2)Ph)Cl] (3), [Cu(2BzPh)Cl] (4). [Cu(2BzpClPh)Cl] (5) and [Cu(2BzpNO(2)Ph)Cl] (6) were obtained with 2-acetylpyridine-phenylhydrazone (H2AcPh), 2-acetylpyridine-para-chloro-phenylhydrazone (H2AcpClPh), 2-acetylpyridine-para-nitro-phenylhydrazone (H2AcpNO(2)Ph), 2-benzoylpyridine-phenylhydrazone (H2BzPh), 2-benzoylpyridine-para-chloro-phenylhydrazone (H2BzpClPh) and 2-benzoylpyridine-para-nitro-phenylhydrazone (H2BzpNO(2)Ph). The hydrazones showed poor antibacterial effect against Staphylococcus aureus, Enterococcus faecalis and Pseudomonas aeruginosa but demonstrated significant antifungal activity against Candida albicans. Upon coordination to copper(II) the antibacterial and antifungal activities appreciably increased. H2AcpClPh, H2BzpClPh and their copper(II) complexes (2) and (5), respectively, were as active as fluconazole against C. albicans. (C) 2012 Elsevier Ltd. All rights reserved.

2-Acetylpyridine- and 2-benzoylpyridine-derived hydrazones and their gallium(III) complexes are highly cytotoxic to glioma cells

2-Acetylpyridine-phenylhydrazone (H2AcPh), its para-chlorophenylhydrazone (H2AcpClPh) and para-nitrophenylhydrazone (H2AcpNO(2)Ph) analogues, the corresponding 2-benzoylpyridine-derived hydrazones (H2BzPh, H2BzpClPh and H2BzpNO(2)Ph) and their gallium(III) complexes were assayed for their cytotoxic activity against U87 (expressing wild-type p53 protein) and T98 (expressing mutant p53 protein) glioma cells. IC50 values against both glioma cells and against the MRC5 (human fetal lung fibroblast) lineage were obtained for the hydrazones, but not for their gallium(III) complexes, due to their low solubility. Hydrazones were highly cytotoxic at nanomolar doses against U87 and T98 cells. The therapeutic indexes (TI = IC50MRC5/IC50glioma) were 2-660 for T98 cells and 28-5000 for U87 cells, indicating that the studied hydrazones could be good antitumor drug candidates to treat brain tumors. (C) 2012 Elsevier Masson SAS. All rights reserved.

Ecotoxicological evaluation of wastewater from 2.4.6-TNT production

During the manufacture of explosives, large amounts of water are used to remove unwanted by-products generated. This water in turn, ends up in wastewater treatment plants or water bodies. The aim of this study was to evaluate the toxic potential of effluent generated by 2.4.6-Trinitrotoluene (TNT) production, yellow water, red water and mixture of yellow and red water, produced from a plant located in the Paraiba Valley, Sao Paolo state, Brazil. Daphnia similis, Danio rerio, Escherichia coli, Pseudomonas putida and Pseudokircheneriella subcaptata were used as test organisms. Physicochemical parameters such as color, pH, conductivity, total dissolved solids, dissolved oxygen, chemical oxygen demand (COD) and biochemical oxygen demand (BOD) were evaluated. Effluent from 2.4.6-TNT production was extremely toxic to all test organisms. The physicochemical parameters evaluated showed high levels of conductivity (from 41.533 to 42.344 mu S /cm) and chemical oxygen demand (COD of 8471 to 27.364 mg/L) for the effluents analyzed.

N-4-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: Cytotoxicity against human tumor cells, structure-activity relationship studies and investigation on the mechanism of action

N-4-Phenyl 2-acetylpyridine thiosemicarbazone (H2Ac4Ph; N-(phenyl)-2-(1-(pyridin-2-yl)ethylidene) hydrazinecarbothioamide) and its N-4-ortho-, -meta- and -para-fluorophenyl (H2Ac4oFPh, H2Ac4mFPh, H2Ac4pFPh), N-4-ortho-, -meta- and -para-chlorophenyl (H2Ac4oClPh, H2Ac4mClPh, H2Ac4pClPh), N-4-ortho-, -meta- and -para-iodophenyl (H2Ac4oIPh, H2Ac4mIPh, H2Ac4pIPh) and N-4-ortho-, -meta- and -para-nitrophenyl (H2Ac4oNO(2)Ph, H2Ac4mNO(2)Ph, H2Ac4pNO(2)Ph) derivatives were assayed for their cytotoxicity against human malignant breast (MCF-7) and glioma (T98G and U87) cells. The compounds were highly cytotoxic against the three cell lineages (IC50: MCF-7, 52-0.16 nM; T98G, 140-1.0 nM; U87, 160-1.4 nM). All tested thiosemicarbazones were more cytotoxic than etoposide and did not present any haemolytic activity at up to 10(-5) M. The compounds were able to induce programmed cell death. H2Ac4pClPh partially inhibited tubulin assembly at high concentrations and induced cellular microtubule disorganization. (C) 2012 Elsevier Ltd. All rights reserved.

GLP-2 receptors in human disease: high expression in gastrointestinal stromal tumors and Crohn's disease

Peptide hormones of the glucagon-like peptide (GLP) family play an increasing clinical role, as reported for GLP-1 in diabetes therapy and insulinoma diagnostics. GLP-2, despite its known trophic and anti-inflammatory intestinal actions translated into preliminary clinical studies using the GLP-2 analogue teduglutide for treatment of short bowel syndrome and Crohn's disease, remains poorly characterized in terms of expression of its receptor in tissues of interest. Therefore, the GLP-2 receptor expression was assessed in 237 tumor and 148 non-neoplastic tissue samples with in vitro receptor autoradiography. A GLP-2 receptor expression was present in 68% of gastrointestinal stromal tumors (GIST). Furthermore, GLP-2 receptors were identified in the intestinal myenteric plexus, with significant up-regulation in active Crohn's disease. The GLP-2 receptors in GIST may be used for clinical applications like in vivo targeting with radiolabelled GLP-2 analogues for imaging and therapy. Moreover, the over-expressed GLP-2 receptor in the myenteric plexus may represent the morphological correlate of the clinical target of teduglutide in Crohn's disease.

Prevalence of type 2 diabetes is higher in peripheral artery disease than in coronary artery disease patients.

Type 2 diabetes mellitus and pre-diabetes are risk factors for atherosclerosis and are highly prevalent in patients with coronary artery disease. However, the prevalence of impaired glucose metabolism in patients with peripheral artery disease is not as well elucidated. We aimed at comparing prevalence rates of type 2 diabetes mellitus and pre-diabetes, which were diagnosed according to the current American Diabetes Association criteria, among 364 patients with peripheral artery disease, 529 patients with coronary artery disease and 383 controls. The prevalence of type 2 diabetes mellitus in peripheral artery disease patients was 49.7%. It was significantly higher in these patients than in coronary artery disease patients (34.4%; p < 0.001) and controls (21.4%; p < 0.001). Adjusted for sex, age and body mass index, odds ratios for type 2 diabetes mellitus were 2.0 (95% confidence interval 1.5-2.6) comparing the peripheral artery disease group with the coronary artery disease group (p < 0.001) and 4.0 (2.8-5.8) comparing the peripheral artery disease group with controls (p < 0.001). The prevalence of pre-diabetes among non-diabetic subjects was high in all three study groups (64.5% in peripheral artery disease patients, 63.4% in coronary artery disease patients and 61.8% in controls), without significant between-group differences. In conclusion, the prevalence of type 2 diabetes mellitus is even higher in peripheral artery disease patients than in coronary artery disease patients. This observation underlines the need to consider impaired glucose regulation in the management of peripheral artery disease.

Signatures of the 2-day wave and sudden stratospheric warmings in Arctic water vapour observed by ground-based microwave radiometry

The ground-based microwave radiometer MIAWARA-C recorded the upper stratospheric and lower mesospheric water vapour distribution continuously from June 2011 to March 2013 above the Arctic station of Sodankylä, Finland (67.4° N, 26.6° E) without major interruptions and offers water vapour profiles with temporal resolution of 1 h for average conditions. The water vapour time series of MIAWARA-C shows strong periodic variations in both summer and winter related to the quasi-2-day wave. Above 0.1 hPa the amplitudes are strongest in summer. The stratospheric wintertime 2-day wave is pronounced for both winters on altitudes below 0.1 hPa and reaches a maximum amplitude of 0.8 ppmv in November 2011. Over the measurement period, the instrument monitored the changes in water vapour linked to two sudden stratospheric warmings in early 2012 and 2013. Based on the water vapour measurements, the descent rate in the vortex after the warmings is 364 m d−1 for 2012 and 315 m d−1 for 2013.

Immunodeficiency and the risk of cervical intra-epithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV Cohort Study.

HIV-infected women are at increased risk of cervical intra-epithelial neoplasia (CIN) and invasive cervical cancer (ICC), but it has been difficult to disentangle the influences of heavy exposure to HPV infection, inadequate screening, and immunodeficiency. A case-control study including 364 CIN2/3 and 20 ICC cases matched to 1,147 controls was nested in the Swiss HIV Cohort Study (1985-2013). CIN2/3 risk was significantly associated with low CD4+ cell counts, whether measured as nadir (odds ratio (OR) per 100-cell/μL decrease=1.15, 95% CI: 1.08, 1.22), or at CIN2/3 diagnosis (1.10, 95% CI: 1.04, 1.16). An association was evident even for nadir CD4+ 200-349 versus ≥350 cells/μL (OR=1.57, 95% CI: 1.09, 2.25). After adjustment for nadir CD4+, a protective effect of >2-year cART use was seen against CIN2/3 (OR versus never cART use=0.64, 95% CI: 0.42, 0.98). Despite low study power, similar associations were seen for ICC, notably with nadir CD4+ (OR for 50 versus >350 cells/μL= 11.10, 95% CI: 1.24, 100). HPV16-L1 antibodies were significantly associated with CIN2/3, but HPV16-E6 antibodies were nearly exclusively detected in ICC. In conclusion, worsening immunodeficiency, even at only moderately decreased CD4+ cell counts (200-349 CD4+ cells/μL), is a significant risk factor for CIN2/3 and cervical cancer. This article is protected by copyright. All rights reserved.

Na 50 Nachlass Arthur Schopenhauer - 'Schopenhauer-Archiv', 364 - Streitigkeiten bei der Verlegung ihrer Bücher

u.a.: Buchhändler Johann David Sauerländer;

Ms.Ff.F.Stoltze 3. 364 - Brief von Friedrich Stoltze an Feodor Körber

Frankfurter Latern: Probenummer, Korrektur, Revision, Satzanweisungen, "Frankfurter Nikelose-Zeitung"

Na 1 Nachlass Max Horkheimer, 655 - Vorträge über Antisemitismus (p. IX 40.1-2-IX 48.1-2)

"Summer institute on Modern European Culture" (1947?); 1. Ankündigung für eine Vorlesungsreihe von Max Horkheimer, Theodor W. Adorno, Leo Löwenthal, Herbert Marcuse, Friedrich Pollock. a) Typoskript mit eigenhändigen Ergänzungen, 20 Blatt b) Typoskript mit handschriftlichen Ergänzungen, 19 Blatt; 2. Herbert Marcuse: "Philosophie allemande et francaise 1871-1933". Typoskript mit eigenhändigen Korrekturen, 18 Blatt; "Tentative Program for the Course of Antisemitism". Vorlesungsankündigung 1948 von Max Horkheimer, Theodor W. Adorno, Friedrich Pollock. Typoskript 2 Blatt; Max Horkheimer: Bericht über die Antisemitismus-Forschungen des Instituts für Sozialforschung (GS 12, S. 165-171). Vortrag gehalten am 16.4.1943, englischer Text. a) Typoskript mit eigenhändigen Korrekturen, 5 Blatt b) Typoskript mit eigenhändigen Korrekturen, 8 Blatt c) Typoskript mit handschriftlichen Korrekturen, 8 Blatt; Max Horkheimer: Bericht über die Antisemitismus-Forschungen des Instituts für Sozialforschung (GS 12, S. 172-183). Vortrag gehalten am 30.4.1943, Temple Israel. a) Typoskript mit eigenhändigen Korrekturen und Ergänzungen, 12 Blatt b) Typoskript mit handschriftlichen Korrekturen, 11 Blatt c) Typoskript mit eigenhändigen Korrekturen, 14 Blatt; Max Horkheimer: Über die Psychologie des Judentums und des Antisemitismus; 1. Vortrag, gehalten am 7.10.1943 im Department of Psychology, UCLA, eigenhändige Notizen, 1 Blatt; 2. Auszüge aus Schriften und Arbeitspapieren von: G.M. Davidson, Salomon Andhil Fineberg, A.R.L. Gurland, Oscar I. Janomsky, Paul W. Massing, Typoskript mit eigenhändigen Ergänzungen, 8 Blatt; Max Horkheimer: Anti-Semitism as a Social Phenomenon (GS 5, S.364-372); 1. Vortrag, gehalten am 17.6.1944 in San Francisco, Psychoanalytic Society, veröffentlicht unter dem Titel 'Sociological Background of the Psychoanalytic Approach". In: Ernst Simmel (ed.), "Anti-Semitism. A Social Disease", New York, 1946, S.1-10. a) Typoskript, 13 Blatt, b) Teilstück, Typoskript, 1 Blatt, c) Teilstück, Typoskript mit eigenhändigen Korrekturen, 2 Blatt d) Typoskript mit handschriftlichen Korrekturen, 9 Blatt; 2. "Notes to the Speech in San Francisco", Notizen, 4 Blatt; 3. eigenhändige Notizen zum Vortrag, 5 Blatt; 4. Rede für Maurice Karpf, Typoskript mit eigenhändigen Korrekturen, 2 Blatt; 5. Theodor W. Adorno: "Mammoth Motives", Notizen zum Verhältnis von Soziologie und Psychologie des Antisemitismus, 3 Blatt; 6. Theodor W. Adorno: "Patterns of Anti-Democratic Propaganda", veröffentlicht in: Ernst Simmel, "Anti-Semitism. A Social Disease", New York, 1946, S.125-137. a) Typoskript, 15 Blatt, b) Typoskript, 14 Blatt;; 7. Einladung, Drucksache, 2 Blatt; 8. Max Horkheimer: 2 Brief an Donald MacFerlane, Pacific Palisades, 22.5.1944, 1 Blatt; Max Horkheimer: Vorträge 1944-45; 1. "Report for the N.C.R.A.C.". Über Forschungsprojekte des American Jewish Committee and des American Jewish Congress, vorgetragen am 14.1.1944, Typoskript, 4 Blatt; 2. Notizen zu 1: Über Kurt Lewin, Typoskript, 3 Blatt; 3. eigenhändige Notizen zu 1., 3 Blatt; 4. Über die europäische Tradition der Arbeiten des Instituts für Sozialforschung. Vortrag, gehalten am 8.12.1944. Eigenhändige Notizen, 1 Blatt; 5. Über psychologische Aspekte der Antisemitismusforschung des Instituts für Sozialforschung. Vortrag, gehalten am 19.4.1945. Eigenhändige Notizen, 2 Blatt; 6. Über sozioökonomische Aspekte des Antisemitismus in Europa und in der Arbeiterschaft der USA. Vortrag, gehalten am 8.6.1945. Psychosomatic Society a) Notizen zum Vortrag, 4 Blatt, b) eigenhändige Notizen, 3 Blatt; 7. Notizen zu 6., Typoskript, 17 Blatt,; 8. Notizen zu 6. "Quotations from Labor Study", Typoskript, 12 Blatt; 9. Über neue Forschungsprojekte des Instituts für Sozialforschung zum Antisemitismus. Vortrag, gehalten am 24.10.1945. Eigenhändige Notizen, 2 Blatt; 10. Über Antisemitismus. Vortrag, gehalten am 3.12.1945. Eigenhändige Notizen, 2 Blatt; 11.-15. Vorträge über Antisemitismus. Datierung unklar (etwa 1945) (u.a. "Mountvernon Speech" und "Breakfast Speech"), 17 Blatt; 16. Über Judentum und Katholizismus in der neueren Geschichte. Eigenhändige Notizen zu einem Vortrag, Datierung unklar, 3 Blatt; 17. Über Vorurteil, Vortrag oder Diskussion in einer Synagoge, Datierung unklar, eigenhändige Notizen, 1 Blatt; Max Horkheimer: Über die Antisemitismus-Forschungen des Instituts für Sozialforschung. Vortrag, gehalten beim U.C.R.A.C.-Meeting, 15.-17.6.1946, Chicago:; 1. eigenhändige Notizen, 13 Blatt; 2. Fragebogen, als Typoskript vervielfältigt, mit eigenhändigen Ergänzungen, 6 Blatt;